Introduction to Dexamethasone Sodium Phosphate
Dexamethasone Sodium Phosphate, identified by the National Drug Code (NDC) 67457-0422, is a corticosteroid used in various medical applications, including intra-articular, intralesional, intramuscular, intravenous, and soft tissue injections. It is a potent anti-inflammatory and immunosuppressive agent[1].
Market Context
Current Market Trends
The pharmaceutical market is dynamic, with ongoing changes in pricing, regulatory requirements, and technological advancements. For instance, the summer 2024 Pharmacy Market Outlook by Vizient Inc. highlights the increasing focus on advanced therapies like gene therapy, which may impact the overall pharmaceutical pricing landscape[3].
Drug Pricing Inflation
As of the latest projections, the overall drug price inflation rate for 2025 is expected to be around 0.00%, indicating a stable pricing environment for many pharmaceuticals. However, this does not necessarily reflect the pricing dynamics for specific drugs like Dexamethasone Sodium Phosphate[3].
Pricing and Cost Analysis
Current Pricing
The pricing of Dexamethasone Sodium Phosphate can vary based on the package size and the vendor. However, specific pricing details for NDC 67457-0422 are not readily available in the public domain. Generally, corticosteroids like Dexamethasone Sodium Phosphate are priced based on their strength, dosage form, and package size.
Historical Pricing
Historical data on pricing can provide insights into potential future trends. For example, the Missouri Specialty MAC list, while not specifically mentioning Dexamethasone Sodium Phosphate, shows how prices for other drugs can fluctuate over time. This list indicates that prices can increase or decrease based on various market and regulatory factors[2].
Regulatory Environment
National Drug Code (NDC) Directory
The FDA's National Drug Code Directory is crucial for understanding the regulatory status of drugs. The NDC Directory includes information on finished, unfinished, and compounded drug products. However, the assignment of an NDC number does not imply FDA approval of the product[4][5].
Compliance and Listing
Drug establishments must update their drug listing data in June and December of each year to reflect any changes. This ensures that the NDC Directory remains accurate and up-to-date. Any errors or discrepancies in the NDC Directory should be reported to the FDA[5].
Market Projections
Stability in Pricing
Given the expected 0.00% overall drug price inflation rate for 2025, it is likely that the price of Dexamethasone Sodium Phosphate will remain relatively stable. However, this projection is general and may not reflect specific market pressures or changes in demand and supply for this particular drug.
Demand and Supply Dynamics
The demand for corticosteroids like Dexamethasone Sodium Phosphate can be influenced by various factors, including the prevalence of conditions they treat, such as inflammatory diseases and autoimmune disorders. Any changes in these factors could impact pricing.
Competitive Landscape
Generic and Branded Versions
Dexamethasone Sodium Phosphate is available in both generic and branded forms. The presence of generic versions can lead to price competition, potentially stabilizing or reducing prices over time.
Market Share
Understanding the market share of different manufacturers and distributors of Dexamethasone Sodium Phosphate can provide insights into pricing strategies. Companies with a larger market share may have more leverage to influence prices.
Conclusion
The market analysis and price projections for Dexamethasone Sodium Phosphate (NDC: 67457-0422) suggest a relatively stable pricing environment in the near future. Here are some key points to consider:
- Stable Pricing: The overall drug price inflation rate for 2025 is projected to be 0.00%, indicating stable prices.
- Regulatory Compliance: The FDA's NDC Directory and compliance requirements ensure that drug listings are accurate and up-to-date.
- Demand and Supply: Changes in demand and supply can impact pricing, but current projections suggest stability.
- Competitive Landscape: The presence of generic versions and market share dynamics can influence pricing strategies.
Key Takeaways
- Pricing Stability: Expected stable pricing environment for Dexamethasone Sodium Phosphate in 2025.
- Regulatory Compliance: Adherence to FDA regulations is crucial for maintaining accurate drug listings.
- Market Dynamics: Demand and supply factors, as well as competitive landscape, can influence pricing.
- Generic Competition: Presence of generic versions can stabilize or reduce prices.
FAQs
Q: What is the National Drug Code (NDC) for Dexamethasone Sodium Phosphate?
A: The NDC for Dexamethasone Sodium Phosphate is 67457-0422.
Q: What are the common uses of Dexamethasone Sodium Phosphate?
A: It is used for intra-articular, intralesional, intramuscular, intravenous, and soft tissue injections to treat various inflammatory and autoimmune conditions.
Q: What is the expected drug price inflation rate for 2025?
A: The overall drug price inflation rate for 2025 is projected to be around 0.00%.
Q: How often must drug establishments update their drug listing data?
A: Drug establishments must update their drug listing data in June and December of each year.
Q: Does the assignment of an NDC number imply FDA approval?
A: No, the assignment of an NDC number does not imply FDA approval of the product.
Sources
- SEER CanMED: Dexamethasone Sodium Phosphate - CanMED: NDC[1]
- Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023[2]
- Vizient Inc.: Pharmacy Market Outlook Summer 2024[3]
- FDA: National Drug Code Directory[4]
- FDA: National Drug Code Database Background Information[5]
